SCHEMBL15624226

SCHEMBL15624226

C(=C/c1nc2ccccc2[nH]1)\c1ccc(N(c2ccc(/C=C/c3nc4ccccc4[nH]3)cc2)c2ccc(/C=C/c3nc4ccccc4[nH]3)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 13/20 0.73
▸ RAB9A P51151 13/20 0.73
▸ KMT2A Q03164 11/20 0.73
▸ MEN1 O00255 10/20 0.73
▸ KDM4E B2RXH2 10/20 0.73
▸ ALDH1A1 P00352 8/20 0.73
▸ SMN1; SMN2 Q16637 5/20 0.73
▸ HPGD P15428 4/20 0.73
▸ PKM P14618 3/20 0.73
▸ HSP90AA1 P07900 1/20 0.73
▸ MAPT P10636 11/20 0.70
▸ LMNA P02545 5/20 0.70
▸ GAA P10253 4/20 0.70
▸ GLA P06280 2/20 0.70
▸ TP53 P04637 1/20 0.70
▸ ATP4A P20648 1/20 0.56
▸ ATP4B P51164 1/20 0.56
▸ HTT P42858 3/20 0.54
▸ NFKB1 P19838 2/20 0.54
▸ NFKB2 Q00653 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305038 0.90 NPC1 (0.89) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL31252953 0.88 MAPT (0.71) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL2497906 0.88 MAPT (0.71) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL2497904 0.88 MAPT (0.71) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL1298605 0.87 MAPT (0.66) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL31252955 0.87 MAPT (0.66) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL1298603 0.87 MAPT (0.66) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL537905 0.85 NPC1 (1.00) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL29660212 0.85 NPC1 (1.00) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL537904 0.85 NPC1 (1.00) NPC1RAB9AKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014044757-A1 CATIONIC TRIPHENYLAMINE DERIVATIVES ACTIVABLE BY VISIBLE AND INFRA RED LIGHT FOR INDUCING AND IMAGING APOPTOSIS IN CANCER CELLS INSTITUT CURIE (FR) 2014-03-27 — — WO disclosed
EP-2711366-A1 Cationic triphenylamine derivatives activable by visible and Infra Red light for inducing and imaging apoptosis in cancer cells Institut Curie (FR) 2014-03-26 — — EP disclosed
Send feedback